AI-assisted wound measurement and documentation—built for clinicians.
3D wound modeling, trend analytics, and explainable guidance that fit existing workflows.
Under development; not for diagnostic use.
Clinical-Grade Tools for Wound Care
Designed to reduce burden, improve measurement consistency, and support better outcomes—without replacing professional judgment.
3D Wound Modeling
Automated surface and volume estimates to reduce measurement variance.
Analytics & Trends
Longitudinal views, risk flags, and response-to-care tracking.
Conversational Intake
Patient Q&A transformed into structured, chart-ready output.
EHR-Ready Exports
FHIR-friendly, CSV/JSON formats to minimize double-charting.
Privacy & Security
HIPAA-aligned design, encryption, RBAC, and audit logging.
Clinician-in-the-Loop
Transparent guidance with citations and override capability.
How MediMorphAI Fits Your Workflow
Capture
Bedside image capture with guided positioning
Compute
Automated metrics and wound characterization
Review
Clinician review and approval with override options
Export
Direct integration with EHR systems
Clinical Evidence Plan
Rigorous validation with partner sites to ensure clinical fit and performance.
Clinical Fit & Evidence
Bedside capture → metrics → draft note → review → export
Measurement consistency, documentation time, workflow fit
Wound centers, inpatient consults, VA/DoD, SNF
Pilot Metrics (Targets)
Illustrative targets; finalize with partner sites & IRB.
Development Roadmap
Decision-grade milestones toward clinical validation and market access. Exit criteria guide each phase transition.
Now (Alpha)
Bench + synthetic/phantom validation; core UX hardening; design inputs drafted.
Measurement workflow stable; preliminary variance targets set; pilot LOIs gathered.
Near Term (Pilot Prep)
IRB/ethics package, DUA/BAA, design controls kickoff, data mgmt & de-ID SOPs, IFU v0.5.
Site onboarding complete; training plan approved; pilot protocol ready to execute.
Regulatory (Validation)
Multi-site observational data collection; V&V; predicate mapping for 510(k).
Pre-specified endpoints met; V&V report; submission dossier assembled.
Launch (Early Access)
Early access cohorts; reference sites; support/readiness; post-market surveillance plan.
Go-live checklist passed; support SLAs in place; PMCF/PMS plan active.
• Timeline is illustrative; regulatory clearance not yet obtained.
• No patient data shown.
• Performance metrics represent targets pending validation; no efficacy claims until clinical studies complete.
About Inovasity
We're building assistive AI tools to reduce clinician burden, improve measurement consistency, and support better patient outcomes—without replacing professional judgment.
Interoperable
Built to fit existing systems and workflows
Explainable
Transparent outputs with traceable reasoning
Secure
HIPAA-aligned architecture and data handling
Partner-Driven
Co-developed with frontline clinicians
Frequently Asked Questions
Get in Touch
Interested in early access or partnership? We'd love to hear from you.
Or email us directly: